Like a woman’s libido, the name of the new drug approved to treat female sexual dysfunction is hard to understand—let alone pronounce. Yes, as if women struggling with hypoactive sexual desire ...
Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since she started the medication We had a wonderful family life growing up. I ...
On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...
Amaze Lab on MSN
FDA approves first ever female libido pill—with one catch
The U.S. Food and Drug Administration recently expanded approval of Addyi, a daily pill for low sex drive, to postmenopausal women up to age 65. This change could reach millions more women but faces ...
Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...
More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot ...
WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...
Ten years since the landmark approval of the first and only FDA-authorized pill clinically proven to treat low libido in women, Sprout Pharmaceuticals CEO Cindy Eckert reflects on advancements and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback